Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study

This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*

2016 (EN)
Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study (EN)

Iudice, Salvatore
Prinzio, Manuela
Martino, Giuseppina
Ongarelli, Cristina
Onidi, Francesca Maria
Puthiavettil, Reetha
Schiavoni, Elisa
Biagini, Silvia
Sardi, Romina
Guarini, Alessandra
Carretto, Daniela
Marziali, Barbara
Capaldi, Antonella
Sinatora, Rita
De Angelis, Anna
Mattiola, Roberta
Zullo, Angelo

Background The satisfaction perceived by patients with chronic diseases affects clinical outcomes and healthcare costs. Some patients with inflammatory bowel disease (IBD) develop a more severe form requiring biologic therapy. We assessed the quality of care perceived by IBD patients in dedicated centers.Methods This prospective, cross-sectional, multicenter study enrolled consecutive IBD patients who underwent biologic therapy in the participating centers. The nurses directly involved in the management of these patients explained the rationale of the survey, provided a specific questionnaire (CACHE), and collected data. The CACHE included 31 items structured in 6 domains: staff care, clinician care, center facilities, patient information, accessibility, and patient support. Patients' satisfaction score for each domain ranged from 0 to 100%.Results Sixteen different Italian centers participated and a total of 450 patients were enrolled (283 with Crohn's disease and 167 with ulcerative colitis). The overall score was 82.2±19.6, satisfaction with the clinicians care scoring the highest (87.6±3.2) and the information provided to the patient scoring the lowest (70.7±7.9). More specifically, it emerged that 5.2-19.5% of patients were unsatisfied with: 1) the communication between the IBD medical team and primary care physicians; 2) information received about the disease or patients' associations; and 3) the accessibility of the center.Conclusion Although our data revealed an acceptably high rate of global satisfaction among IBD patients receiving biologic therapy, more effort should be made to improve patient information and communication between IBD teams, other specialists and primary care physicians.Keywords Inflammatory bowel disease, Crohn's disease, ulcerative colitis, biologic therapy, patient satisfactionAnn Gastroenterol 2017; 30 (1): 96-100 (EN)




Hellenic Society of Gastroenterology (EN)

Annals of Gastroenterology; Volume 30, No 1 (2017); 96 (EN)

*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)